Prevalence and Predictors of Inappropriate Prescribing in Outpatients with Severe Mental Illness

Overview

Journal Ther Adv Psychopharmacol

Specialty Psychiatry

Date 2023 Nov 29

PMID 38022837

Authors

Lisanne Koomen

Ilona van de Meent

Floor Elferink

Ingeborg Wilting

Wiepke Cahn

Affiliations

Soon will be listed here.

Abstract

Background: Potentially inappropriate prescribing (PIP) is frequent in geriatrics and results in an increased risk for adverse effects, morbidity, mortality and reduced quality of life. Research on PIP in psychiatry has mainly focused on elderly patients and inpatients.

Objectives: To determine the prevalence and the predictors of PIP of psychotropic medication in outpatients with severe mental illness.

Design: This study is part of the Muva study, a pragmatic open Stepped Wedge Cluster Randomized Trial of a physical activity intervention for patients (age ⩾ 16 years) with severe mental illness.

Methods: A structured medication interview, questionnaires on social functioning, quality of life and psychiatric symptoms, and BMI and waist circumference measurements were performed followed by a structured medication review. Patients were divided into groups: PIP no PIP. Between-group differences were calculated and a multivariate binary logistic regression was performed to examine predictors for PIP. A receiver operating characteristics analysis was performed to determine the area under the curve (AUC).

Results: In 75 patients, an average of 5.2 medications of which 2.5 psychotropic medication was used. 35 (46.7%) patients were identified with PIP. Unindicated long-term benzodiazepine use was the most frequently occurring PIP (34.1%). Predictors of PIP were female gender [odds ratio (OR) = 4.88, confidence interval (CI) = 1.16-20.58, = 0.03], number of medications (OR = 1.41, CI = 1.07-1.86, = 0.02) and lower social functioning (OR = 1.42, CI = 1.01-2.00, = 0.05). The AUC was 0.88 for the combined prediction model.

Conclusion: The prevalence of PIP of psychotropic medication in outpatients with severe mental illness is high. It is therefore important to identify, and where possible, resolve PIP by frequently performing a medication review with specific attention to females, patients with a higher number of medications and patients with lower social functioning.

Trial Registration: This trial was registered in The Netherlands Trial Register (NTR) as NTR NL9163 on 20 December 2020 (https://trialsearch.who.int/Trial2.aspx?TrialID=NL9163).

References

Firth J, Siddiqi N, Koyanagi A, Siskind D, Rosenbaum S, Galletly C . The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness. Lancet Psychiatry. 2019; 6(8):675-712. DOI: 10.1016/S2215-0366(19)30132-4. View

Stuhec M . Clinical pharmacist consultant in primary care settings in Slovenia focused on elderly patients on polypharmacy: successful national program from development to reimbursement. Int J Clin Pharm. 2021; 43(6):1722-1727. DOI: 10.1007/s11096-021-01306-2. View

Taipale H, Tanskanen A, Mehtala J, Vattulainen P, Correll C, Tiihonen J . 20-year follow-up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20). World Psychiatry. 2020; 19(1):61-68. PMC: 6953552. DOI: 10.1002/wps.20699. View

Marazziti D, Baroni S, Picchetti M, Piccinni A, Carlini M, Vatteroni E . Pharmacokinetics and pharmacodynamics of psychotropic drugs: effect of sex. CNS Spectr. 2013; 18(3):118-27. DOI: 10.1017/S1092852912001010. View

Fond G, Tinland A, Boucekine M, Girard V, Loubiere S, Auquier P . Prescription of potentially inappropriate psychotropic drugs in homeless people with schizophrenia and bipolar disorders. Results from the French Housing First (FHF) program. Prog Neuropsychopharmacol Biol Psychiatry. 2018; 89:84-89. DOI: 10.1016/j.pnpbp.2018.08.024. View

Hefner G, Stieffenhofer V, Gabriel S, Palmer G, Muller K, Roschke J . Side effects related to potentially inappropriate medications in elderly psychiatric patients under everyday pharmacotherapy. Eur J Clin Pharmacol. 2014; 71(2):165-72. DOI: 10.1007/s00228-014-1796-5. View

Gnjidic D, Hilmer S, Blyth F, Naganathan V, Waite L, Seibel M . Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol. 2012; 65(9):989-95. DOI: 10.1016/j.jclinepi.2012.02.018. View

Scott I, Hilmer S, Reeve E, Potter K, Le Couteur D, Rigby D . Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015; 175(5):827-34. DOI: 10.1001/jamainternmed.2015.0324. View

Ishtiak-Ahmed K, Kohler-Forsberg O, Mortensen E, Nierenberg A, Gasse C . Concurrent use of polypharmacy and potentially inappropriate medications with antidepressants in older adults: A nationwide descriptive study in Denmark during 2015-2019. Gen Hosp Psychiatry. 2023; 82:66-74. DOI: 10.1016/j.genhosppsych.2023.03.009. View

10.

Wolff J, Hefner G, Normann C, Kaier K, Binder H, Hiemke C . Polypharmacy and the risk of drug-drug interactions and potentially inappropriate medications in hospital psychiatry. Pharmacoepidemiol Drug Saf. 2021; 30(9):1258-1268. DOI: 10.1002/pds.5310. View

11.

Fond G, Fajula C, Dassa D, Brunel L, Lancon C, Boyer L . Potentially inappropriate psychotropic prescription at discharge is associated with lower functioning in the elderly psychiatric inpatients. A cross-sectional study. Psychopharmacology (Berl). 2016; 233(13):2549-58. DOI: 10.1007/s00213-016-4312-z. View

12.

Evrard P, Petein C, Beuscart J, Spinewine A . Barriers and enablers for deprescribing benzodiazepine receptor agonists in older adults: a systematic review of qualitative and quantitative studies using the theoretical domains framework. Implement Sci. 2022; 17(1):41. PMC: 9264665. DOI: 10.1186/s13012-022-01206-7. View

13.

OConnor M, Gallagher P, OMahony D . Inappropriate prescribing: criteria, detection and prevention. Drugs Aging. 2012; 29(6):437-52. DOI: 10.2165/11632610-000000000-00000. View

14.

Rongen S, Kramers C, OMahony D, Feuth T, Olde Rikkert M, Ahmed A . Potentially inappropriate prescribing in older patients admitted to psychiatric hospital. Int J Geriatr Psychiatry. 2015; 31(2):137-45. DOI: 10.1002/gps.4302. View

15.

Hill-Taylor B, Sketris I, Hayden J, Byrne S, OSullivan D, Christie R . Application of the STOPP/START criteria: a systematic review of the prevalence of potentially inappropriate prescribing in older adults, and evidence of clinical, humanistic and economic impact. J Clin Pharm Ther. 2013; 38(5):360-72. DOI: 10.1111/jcpt.12059. View

16.

Gerlach J, Korsgaard S, Clemmesen P, Lauersen A, Magelund G, Noring U . The St. Hans Rating Scale for extrapyramidal syndromes: reliability and validity. Acta Psychiatr Scand. 1993; 87(4):244-52. DOI: 10.1111/j.1600-0447.1993.tb03366.x. View

17.

Sharma R, Bansal P, Sharma A, Chhabra M, Bansal N, Arora M . Clonazepam tops the list of potentially inappropriate psychotropic (PIP) medications in older adults with psychiatric illness: A cross-sectional study based on Beers criteria 2019 vs STOPP criteria 2015. Asian J Psychiatr. 2021; 58:102570. DOI: 10.1016/j.ajp.2021.102570. View

18.

Werremeyer A, Bostwick J, Cobb C, Moore T, Park S, Price C . Impact of pharmacists on outcomes for patients with psychiatric or neurologic disorders. Ment Health Clin. 2020; 10(6):358-380. PMC: 7653731. DOI: 10.9740/mhc.2020.11.358. View

19.

Maund E, Dewar-Haggart R, Williams S, Bowers H, Geraghty A, Leydon G . Barriers and facilitators to discontinuing antidepressant use: A systematic review and thematic synthesis. J Affect Disord. 2018; 245:38-62. DOI: 10.1016/j.jad.2018.10.107. View

20.

Gupta S, Cahill J . A Prescription for "Deprescribing" in Psychiatry. Psychiatr Serv. 2016; 67(8):904-7. DOI: 10.1176/appi.ps.201500359. View